BiotechTubeBiotechTube
Home/Adagene/Yan Feng
YF

Yan Feng

Vice President, Translational Science

Adagene

Therapeutic Areas

OncologyImmuno-Oncology

Adagene Pipeline

DrugIndicationPhase
ADG126Advanced/Metastatic Solid TumorsPhase 1b/2
ADG206Advanced/Metastatic Solid TumorsPhase 1
ADG116Advanced/Metastatic Solid TumorsPhase 1
ADG106Advanced/Metastatic Solid Tumors & Non-Hodgkin LymphomaPhase 1
ADG125Solid TumorsPreclinical
ADG153Solid TumorsPreclinical

Leadership Team at Adagene

PL
Peter Luo
Co-Founder, Chief Executive Officer, Chairman of the Board
XY
Xiaodong Yang
Co-Founder, Chief Scientific Officer
TX
Tian Xie
Co-Founder, Chief Technology Officer
SS
Shan Song
Chief Financial Officer
PS
Peggy S. Berry
President, Head of Global Regulatory Affairs & Quality
AS
Alfred Sandrock, Jr.
Independent Director
LB
Lars Birgerson
Independent Director
SW
Stephanie Wong
Vice President, Clinical Development
LC
Lei Chen
Vice President, Biologics Discovery
View full Adagene profile